Akèy › Kansè san
Etid klinik pou Kansè san ap rekrite nan Etazini
153 etid pou Kansè san ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX46 etid
- New York City, NY26 etid
- Boston, MA25 etid
- Washington, DC19 etid
- Baltimore, MD18 etid
- Seattle, WA18 etid
- Los Angeles, CA17 etid
- Durham, NC16 etid
- Chicago, IL15 etid
- Philadelphia, PA14 etid
- Nashville, TN13 etid
- Atlanta, GA13 etid
- Edison, NJ13 etid
- Columbus, OH13 etid
- Baldwin Park, CA13 etid
- Milwaukee, WI12 etid
- Detroit, MI12 etid
- Dallas, TX12 etid
- Minneapolis, MN11 etid
- Ann Arbor, MI11 etid
- Birmingham, AL11 etid
- Omaha, NE10 etid
- Cincinnati, OH10 etid
- St. Louis, MO10 etid
- Jacksonville, FL10 etid
- Miami, FL9 etid
- Cedar Rapids, IA9 etid
- Memphis, TN9 etid
- Denver, CO9 etid
- Salt Lake City, UT8 etid
- San Antonio, TX8 etid
- San Francisco, CA8 etid
- Aurora, CO8 etid
- Clifton, NJ8 etid
- Tampa, FL8 etid
- Buffalo, NY7 etid
- Madison, WI7 etid
- Grand Rapids, MI7 etid
- Charlotte, NC7 etid
- Portland, OR7 etid
Pa eta
- Alabama11 etid
- Arizona12 etid
- Arkansas5 etid
- Colorado14 etid
- Connecticut8 etid
- Delaware3 etid
- Distrik Columbia7 etid
- Florid28 etid
- Georgia16 etid
- Illinois16 etid
- Indiana9 etid
- Iowa9 etid
- Kalifòni35 etid
- Kansas7 etid
- Kentucky10 etid
- Lwizyàn6 etid
- Maryland29 etid
- Massachusetts26 etid
- Michigan22 etid
- Minnesota17 etid
- Missouri11 etid
- Nebraska10 etid
- Nevada4 etid
- New Hampshire3 etid
- New Jersey21 etid
- New York29 etid
- North Carolina24 etid
- Ohio22 etid
- Oklahoma8 etid
- Oregon8 etid
- Pennsylvania21 etid
- Rhode Island4 etid
- South Carolina8 etid
- South Dakota5 etid
- Tennessee20 etid
- Texas49 etid
- Utah8 etid
- Virginia11 etid
- Washington20 etid
- West Virginia5 etid
- Wisconsin15 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Oct 2, 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Rutgers University Study of the Genetics of Blood Cancers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 110 · Tout sèks · Mizajou Oct 1, 2026 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Ap rekriteEtid obsèvasyon
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06697184A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06910969Genomic Profiling in Cancer Patients
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 24, 2026 · NCT01775072Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
Laj 18 a 71 · Tout sèks · Mizajou Sep 23, 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06587100Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Ap rekriteFaz 1 bonè
Laj 12 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT04744116Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 21, 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT07743476Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 120 · Tout sèks · Mizajou Sep 18, 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT04242095SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05375643Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Ap rekriteFaz 1
Jiska laj 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT06345027Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.